954 related articles for article (PubMed ID: 1700619)
41. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
42. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
[TBL] [Abstract][Full Text] [Related]
43. Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis.
Youssef PP; Triantafillou S; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ; Smith MD
J Rheumatol; 1997 Dec; 24(12):2291-8. PubMed ID: 9415630
[TBL] [Abstract][Full Text] [Related]
44. Hodgkin's disease coexistent with plasma cell dyscrasia.
Zarate-Osorno A; Medeiros LJ; Jaffe ES
Arch Pathol Lab Med; 1992 Sep; 116(9):969-72. PubMed ID: 1524465
[TBL] [Abstract][Full Text] [Related]
45. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.
Wellicome SM; Thornhill MH; Pitzalis C; Thomas DS; Lanchbury JS; Panayi GS; Haskard DO
J Immunol; 1990 Apr; 144(7):2558-65. PubMed ID: 2108206
[TBL] [Abstract][Full Text] [Related]
46. P53 protein expression in lymphomas and reactive lymphoid tissue.
Villuendas R; Piris MA; Orradre JL; Mollejo M; Algara P; Sanchez L; Martinez JC; Martinez P
J Pathol; 1992 Mar; 166(3):235-41. PubMed ID: 1381424
[TBL] [Abstract][Full Text] [Related]
47. Hodgkin's disease: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1978 May; 125(1):39-51. PubMed ID: 569193
[TBL] [Abstract][Full Text] [Related]
48. Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes.
Perfetti V; Dragani TA; Paulli M; Castelli G; Bellotti V; Gobbi PG; Merlini G
Haematologica; 1992; 77(3):221-5. PubMed ID: 1358770
[TBL] [Abstract][Full Text] [Related]
49. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
[TBL] [Abstract][Full Text] [Related]
50. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
51. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1.
Graber N; Gopal TV; Wilson D; Beall LD; Polte T; Newman W
J Immunol; 1990 Aug; 145(3):819-30. PubMed ID: 1695646
[TBL] [Abstract][Full Text] [Related]
52. Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies.
Falini B; Stein H; Pileri S; Canino S; Farabbi R; Martelli MF; Grignani F; Fagioli M; Minelli O; Ciani C
Histopathology; 1987 Dec; 11(12):1229-42. PubMed ID: 2831131
[TBL] [Abstract][Full Text] [Related]
53. Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.
Sinkovics JG
Crit Rev Immunol; 1991; 11(1):33-63. PubMed ID: 1652972
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.
Kovalevska LM; Yurchenko OV; Shlapatska LM; Berdova GG; Mikhalap SV; Van Lint J; Sidorenko SP
Exp Oncol; 2006 Sep; 28(3):225-30. PubMed ID: 17080017
[TBL] [Abstract][Full Text] [Related]
55. Expression of adhesion molecules in human endometrial vasculature throughout the menstrual cycle.
Tabibzadeh S; Kong QF; Babaknia A
J Clin Endocrinol Metab; 1994 Oct; 79(4):1024-32. PubMed ID: 7962270
[TBL] [Abstract][Full Text] [Related]
56. Macrophages and interdigitating reticulum cells in normal human thymus and thymomas: immunoreactivity for interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha.
Ruco LP; Pisacane A; Pomponi D; Stoppacciaro A; Pescarmona E; Rendina EA; Santoni A; Boraschi D; Tagliabue A; Uccini S
Histopathology; 1990 Oct; 17(4):291-9. PubMed ID: 2258168
[TBL] [Abstract][Full Text] [Related]
57. Expression of interleukin-1 receptor antagonist protein in malignant lymphomas. An immunohistochemical study.
Shin SS; Traweek ST; Ulich TR
Arch Pathol Lab Med; 1995 Mar; 119(3):247-51. PubMed ID: 7887778
[TBL] [Abstract][Full Text] [Related]
58. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
59. Functional and molecular characterization of B cell line derived interleukin-1 alpha.
Vyth-Dreese FA; Hekman A; Wijffels J; Geertsma M; Dellemijn TA; Dosda J; Melief CJ; Bertoglio J
Leukemia; 1989 Aug; 3(8):585-92. PubMed ID: 2787453
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.
Schwaller J; Tobler A; Niklaus G; Hurwitz N; Hennig I; Fey MF; Borisch B
Blood; 1995 Apr; 85(8):2182-8. PubMed ID: 7718889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
